Comprehensive Antigen Screening Identifies Moraxella catarrhalis Proteins That Induce Protection in a Mouse Pulmonary Clearance Model

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Smidt, Margarita ^a   Bättig, Patrick ^b   Verhaegh, Suzanne J C ^c   Niebisch, Axel ^a,d   Hanner, Markus ^a   Selak, Sanja ^a   Schüler, Wolfgang ^a   Morfeldt, Eva ^b   Hellberg, Christel ^b   Nagy, Eszter ^a,e   Lundberg, Urban ^a   Hays, John P ^c   Meinke, Andreas ^a   Henriques Normark, Birgitta ^b  

^a INTERCELL AG   (Austria)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d Campus Vienna Biocenter II   (Austria)

^e Arsanis Biosciences GmbH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BINDING PROTEIN; HEME BINDING PROTEIN; MORAXELLA CATARRHALIS PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; CELL LYSATE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE DELETION; GENE LIBRARY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG CLEARANCE; MORAXELLA CATARRHALIS; MOUSE; NONHUMAN; OTITIS MEDIA; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SIGNAL DETECTION;

ADHESINS, BACTERIAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; BLOTTING, WESTERN; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENOMIC LIBRARY; HEMEPROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; LUNG; MICE; MORAXELLA (BRANHAMELLA) CATARRHALIS; MORAXELLACEAE INFECTIONS; OTITIS MEDIA;

EID: 84877347537     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064422     Document Type: Article

References (70)

1. Catlin BW, (1990) Branhamella catarrhalis: an organism gaining respect as a pathogen. ClinMicrobiol Rev 3: 293-320.
2. Enright MC, McKenzie H, (1997) Moraxella (Branhamella) catarrhalis - clinical and molecular aspects of a rediscovered pathogen. J Med Microbiol 46: 360-371.
3. Murphy TF, Bakaletz LO, Kyd JM, Watson B, Klein DL, (2005) Vaccines for otitis media: proposals for overcoming obstacles to progress. Vaccine 23: 2696-2702.
4. Rovers MM, Schilder AG, Zielhuis GA, Rosenfeld RM, (2004) Otitis media. Lancet 363: 465-473.
5. Cripps AW, Otczyk DC, (2006) Prospects for a vaccine against otitis media. Expert Rev Vaccines 5: 517-534.
6. Murphy TF, (2005) Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges. Expert Rev Vaccines 4: 843-853.
7. Mawas F, Ho MM, Corbel MJ, (2009) Current progress with Moraxella catarrhalis antigens as vaccine candidates. Expert Rev Vaccines 8: 77-90.
8. Murphy TF, (2009) Vaccine development for Moraxella catarrhalis: rationale, approaches and challenges. Expert Rev Vaccines 8: 655-658.
9. Ruckdeschel EA, Kirkham C, Lesse AJ, Hu Z, Murphy TF, (2008) Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection. Infect Immun 76: 1599-1607.
10. Chen D, McMichael JC, VanDerMeid KR, Hahn D, Mininni T, et al. (1996) Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization. Infect Immun 64: 1900-1905.
11. Chen D, Barniak V, VanDerMeid KR, McMichael JC, (1999) The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children. Infect Immun 67: 1310-1316.
12. Lafontaine ER, Cope LD, Aebi C, Latimer JL, McCracken GH Jr, et al. (2000) The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro. J Bacteriol 182: 1364-1373.
13. Attia AS, Lafontaine ER, Latimer JL, Aebi C, Syrogiannopoulos GA, et al. (2005) The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance. Infect Immun 73: 2400-2410.
14. Forsgren A, Brant M, Karamehmedovic M, Riesbeck K, (2003) The immunoglobulin D-binding protein MID from Moraxella catarrhalis is also an adhesin. Infect Immun 71: 3302-3309.
15. Aebi C, Stone B, Beucher M, Cope LD, Maciver I, et al. (1996) Expression of the CopB outer membrane protein by Moraxella catarrhalis is regulated by iron and affects iron acquisition from transferrin and lactoferrin. Infect Immun 64: 2024-2030.
16. Murphy TF, Kyd JM, John A, Kirkham C, Cripps AW, (1998) Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model. J Infect Dis 178: 1667-1675.
17. Fritzer A, Senn BM, Minh DB, Hanner M, Gelbmann D, et al. (2010) Novel conserved group A streptococcal proteins identified by the antigenome technology as vaccine candidates for a non-M protein-based vaccine. Infect Immun 78: 4051-4067.
18. Meinke A, Henics T, Hanner M, Minh DB, Nagy E, (2005) Antigenome technology: a novel approach for the selection of bacterial vaccine candidate antigens. Vaccine 23: 2035-2041.
19. Meinke A, Henics T, Nagy E, (2004) Bacterial genomes pave the way to novel vaccines. Curr Opin Microbiol 7: 314-320.
20. Christensen JJ, Ursing J, Bruun B, (1994) Genotypic and phenotypic relatedness of 80 strains of Branhamella catarrhalis of worldwide origin. FEMS Microbiol Lett 119: 155-159.
21. Mollenkvist A, Nordström T, Halldén C, Christensen JJ, Forsgren A, et al. (2003) The Moraxella catarrhalis immunoglobulin D-binding protein MID has conserved sequences and is regulated by a mechanism corresponding to phase variation. J Bacteriol (185) ():: 2285-2295.
22. Etz H, Minh DB, Schellack C, Nagy E, Meinke A, (2001) Bacterial phage receptors, versatile tools for display of polypeptides on the cell surface. J Bacteriol 183: 6924-6935.
23. Schellack C, Prinz K, Egyed A, Fritz JH, Wittmann B, et al. (2006) IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses. Vaccine 24: 5461-5472.
24. Bijlsma JJ, Burghout P, Kloosterman TG, Bootsma HJ, de Jong A, et al. (2007) Development of genomic array footprinting for identification of conditionally essential genes in Streptococcus pneumoniae. Appl Environ Microbiol 73: 1514-1524.
25. Hays JP, Eadie K, Verduin CM, Verbrugh H, van Belkum A, (2005) A novel plasmid (pEMCJH03) isolated from moraxella catarrhalis possibly useful as a cloning and expression vector within this species. Plasmid 53: 263-268.
26. Feissner R, Xiang Y, Kranz RG, (2003) Chemiluminescent-based methods to detect subpicomole levels of c-type cytochromes. Anal Biochem 315: 90-94.
27. Forsgren A, Brant M, Riesbeck K, (2004) Immunization with the truncated adhesin moraxella catarrhalis immunoglobulin D-binding protein (MID764-913) is protective against M. catarrhalis in a mouse model of pulmonary clearance. J Infect Dis 190: 352-355.
28. Bonnah RA, Wong H, Loosmore SM, Schryvers AB, (1999) Characterization of Moraxella (Branhamella) catarrhalis lbpB, lbpA, and lactoferrin receptor orf3 isogenic mutants. Infect Immun 67: 1517-1520.
29. Yu RH, Bonnah RA, Ainsworth S, Schryvers AB, (1999) Analysis of the immunological responses to transferrin and lactoferrin receptor proteins from Moraxella catarrhalis. Infect Immun 67: 3793-3799.
30. Aebi C, Cope LD, Latimer JL, Thomas SE, Slaughter CA, et al. (1998) Mapping of a protective epitope of the CopB outer membrane protein of Moraxella catarrhalis. Infect Immun 66: 540-548.
31. Mathers KE, Goldblatt D, Aebi C, Yu R, Schryvers AB, et al. (1997) Characterisation of an outer membrane protein of Moraxella catarrhalis. FEMS Immunol Med Microbiol 19: 231-236.
32. Thony-Meyer L, (2000) Haem-polypeptide interactions during cytochrome c maturation. Biochim Biophys Acta 1459: 316-324.
33. Murphy TF, Parameswaran GI, (2009) Moraxella catarrhalis, a human respiratory tract pathogen. Clin Infect Dis 49: 124-131.
34. Johnson MA, Drew WL, Roberts M, (1981) Branhamella (Neisseria) catarrhalis - a lower respiratory tract pathogen? J Clin Microbiol 13: 1066-1069.
35. Malmvall BE, (1984) [Branhamella catarrhalis - a respiratory tract pathogen with the ability to produce beta-lactamases]. Lakartidningen 81: 3931-3932.
36. Murphy TF, (1998) Lung infections. 2. Branhamella catarrhalis: epidemiological and clinical aspects of a human respiratory tract pathogen. Thorax 53: 124-128.
37. Nicotra B, Rivera M, Luman JI, Wallace RJ Jr, (1986) Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch Intern Med 146: 890-893.
38. Shann F, (1986) Branhamella catarrhalis, a respiratory tract pathogen. Aust N Z J Med 16: 718.
39. Waters MJ, Steinfort CL, Andrew JH, (1985) Branhamella catarrhalis, a respiratory tract pathogen. Aust N Z J Med 15: 579-584.
40. Meinke A, Storm M, Henics T, Gelbmann D, Prustomersky S, et al. (2009) Composition of the ANTIGENome of Helicobacter pylori defined by human serum antibodies. Vaccine 27: 3251-3259.
41. Balder R, Krunkosky TM, Nguyen CQ, Feezel L, Lafontaine ER, (2009) Hag mediates adherence of Moraxella catarrhalis to ciliated human airway cells. Infect Immun 77: 4597-4608.
42. Pearson MM, Lafontaine ER, Wagner NJ, St Geme JW 3rd, Hansen EJ (2002) A hag mutant of Moraxella catarrhalis strain O35E is deficient in hemagglutination, autoagglutination, and immunoglobulin D-binding activities. Infect Immun 70: 4523-4533.
43. Aebi C, Lafontaine ER, Cope LD, Latimer JL, Lumbley SL, et al. (1998) Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis 035E. Infect Immun 66: 3113-3119.
44. Hoiczyk E, Roggenkamp A, Reichenbecher M, Lupas A, Heesemann J, (2000) Structure and sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesins. Embo J 19: 5989-5999.
45. Sabirov A, Metzger DW, (2008) Mouse models for the study of mucosal vaccination against otitis media. Vaccine 26: 1501-1524.
46. Unhanand M, Maciver I, Ramilo O, Arencibia-Mireles O, Argyle JC, et al. (1992) Pulmonary clearance of Moraxella catarrhalis in an animal model. J Infect Dis 165: 644-650.
47. Becker PD, Bertot GM, Souss D, Ebensen T, Guzman CA, et al. (2007) Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model. Infect Immun 75: 1778-1784.
48. Liu DF, McMichael JC, Baker SM, (2007) Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model. Infect Immun 75: 2818-2825.
49. Ruckdeschel EA, Brauer AL, Johnson A, Murphy TF, (2009) Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis. Vaccine 27: 7065-7072.
50. Yang M, Johnson A, Murphy TF, (2011) Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen. Infect Immun 79: 846-857.
51. Ferguson AD, Deisenhofer J, (2004) Metal import through microbial membranes. Cell 116: 15-24.
52. Locher KP, Rees B, Koebnik R, Mitschler A, Moulinier L, et al. (1998) Transmembrane signaling across the ligand-gated FhuA receptor: crystal structures of free and ferrichrome-bound states reveal allosteric changes. Cell 95: 771-778.
53. Ferguson AD, Deisenhofer J, (2002) TonB-dependent receptors-structural perspectives. Biochim Biophys Acta 1565: 318-332.
54. Afonina G, Leduc I, Nepluev I, Jeter C, Routh P, et al. (2006) Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid. Infect Immun 74: 2224-2232.
55. Murphy ER, Sacco RE, Dickenson A, Metzger DJ, Hu Y, et al. (2002) BhuR, a virulence-associated outer membrane protein of Bordetella avium, is required for the acquisition of iron from heme and hemoproteins. Infect Immun 70: 5390-5403.
56. Tauseef I, Harrison OB, Wooldridge KG, Feavers IM, Neal K, et al. (2011) Influence of the Combination and Phase Variation Status of the Haemoglobin Receptors, HmbR and HpuAB, on Meningococcal Virulence. Microbiology 157: 1446-1456.
57. Garmory HS, Titball RW, (2004) ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies. Infect Immun 72: 6757-6763.
58. Chauhan D, Pandey P, Ogata A, Teoh G, Krett N, et al. (1997) Cytochrome c-dependent and-independent induction of apoptosis in multiple myeloma cells. J Biol Chem 272: 29995-29997.
59. Liu X, Kim CN, Yang J, Jemmerson R, (1996) Wang X. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157.
60. Huttemann M, Pecina P, Rainbolt M, Sanderson TH, Kagan VE, et al. (2011) The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: From respiration to apoptosis. Mitochondrion 11: 369-381.
61. Caroppi P, Sinibaldi F, Fiorucci L, Santucci R, (2009) Apoptosis and human diseases: mitochondrion damage and lethal role of released cytochrome C as proapoptotic protein. Curr Med Chem 16: 4058-4065.
62. Otto BR, Verweij-van Vught AM, MacLaren DM, (1992) Transferrins and heme-compounds as iron sources for pathogenic bacteria. Crit Rev Microbiol 18: 217-233.
63. Furano K, Campagnari AA, (2004) Identification of a hemin utilization protein of Moraxella catarrhalis (HumA). Infect Immun 72: 6426-6432.
64. Furano K, Luke NR, Howlett AJ, Campagnari AA, (2005) Identification of a conserved Moraxella catarrhalis haemoglobin-utilization protein, MhuA. Microbiology 151: 1151-1158.
65. Bingham-Ramos LK, Hendrixson DR, (2008) Characterization of two putative cytochrome c peroxidases of Campylobacter jejuni involved in promoting commensal colonization of poultry. Infect Immun 76: 1105-1114.
66. Stutzmann Meier P, Heiniger N, Troller R, Aebi C, (2003) Salivary antibodies directed against outer membrane proteins of Moraxella catarrhalis in healthy adults. Infect Immun 71: 6793-6798.
67. Verhaegh SJ, de Vogel CP, Riesbeck K, Lafontaine ER, Murphy TF, et al. (2011) Temporal development of the humoral immune response to surface antigens of Moraxella catarrhalis in young infants. Vaccine 29: 5603-5610.
68. Faden H, Hong J, Murphy T, (1992) Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media. Infect Immun 60: 3824-3829.
69. Schaar V, de Vries SP, Perez Vidakovics ML, Bootsma HJ, Larsson L, et al. (2011) Multicomponent Moraxella catarrhalis outer membrane vesicles induce an inflammatory response and are internalized by human epithelial cells. Cell Microbiol 13: 432-449.
70. Perez Vidakovics MLA, Jendholm J, Mörgelin M, Mansson A, Larrson C, et al. (2010) B Cell Activation by Outer Membrane Vesicles - A Novel Virulence Mechanism. PLoS Pathogens 6: 1-19.